NOCD Raises $33 Million To Expand Its OCD Telehealth Treatment Platform

NOCD, which provides treatment for obsessive compulsive-disorder (OCD), raised $33 million in Series B funding. The funds will be used to expand NOCD’s community, reach people earlier in their treatment journey, and offer additional services to assist with their long-term health. Investors F-Prime Capital with Eight Roads Ventures, and Kaiser Permanente Ventures joined NOCD’s existing investors including 7wireVentures, Health Enterprise Partners (HEP), and Chicago Ventures.

NOCD delivers more than 12,000 live telehealth visits per month through a nationwide network of exposure and response prevention (ERP) specialty-trained professionals. Within 90 days, consumers have a . . .